Sanders Capital’s AstraZeneca AZN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02B | Sell |
14,526,862
-542,124
| -4% | -$37.9M | 1.36% | 23 |
|
|
2025
Q1 | $1.11B | Sell |
15,068,986
-117,706
| -0.8% | -$8.65M | 1.66% | 21 |
|
|
2024
Q4 | $995M | Buy |
15,186,692
+212,301
| +1% | +$13.9M | 1.45% | 19 |
|
|
2024
Q3 | $1.17B | Buy |
14,974,391
+29,149
| +0.2% | +$2.27M | 1.69% | 21 |
|
|
2024
Q2 | $1.17B | Buy |
14,945,242
+126,259
| +0.9% | +$9.85M | 1.79% | 18 |
|
|
2024
Q1 | $1B | Buy |
14,818,983
+134,917
| +0.9% | +$9.14M | 1.68% | 23 |
|
|
2023
Q4 | $989M | Buy |
14,684,066
+4,122,965
| +39% | +$278M | 1.83% | 21 |
|
|
2023
Q3 | $715M | Buy |
+10,561,101
| New | +$715M | 1.51% | 26 |
|